In the cerebral cortex, the functional output of projection neurons is fine-tuned by inhibitory neurons present in the network, which use g-aminobutyric acid (GABA) as their main neurotransmitter. Previous studies have suggested that the expression levels of the ratelimiting GABA synthetic enzyme, GAD65, depend on brain derived neurotrophic factor (BDNF)/TrkB activation. However, the molecular mechanisms by which this neurotrophic factor and its receptor controls GABA synthesis are still unknown. Here, we show a direct regulation of the GAD65 gene by BDNF-TrkB signaling via CREB in cortical interneurons. Conditional ablation of TrkB in cortical interneurons causes a cell-autonomous decrease in the synaptically enriched GAD65 protein and its transcripts levels, suggesting that transcriptional regulation of the GAD65 gene is altered. Dissection of the intracellular pathway that underlies this process revealed that BDNF/TrkB signaling controls the transcription of GAD65 in a Ras-ERK-CREB-dependent manner. Our study reveals a novel molecular mechanism through which BDNF/TrkB signaling may modulate the maturation and function of cortical inhibitory circuits.
Introduction
The function of neural networks in the cerebral cortex of vertebrates relies on the interaction between 2 classes of neurons, excitatory projection neurons and inhibitory interneurons. In these circuits, the output of excitatory neurons is fine-tuned and synchronized by the function of inhibitory neurons. In addition, inhibition provides functional balance, complexity, and computational organization to the neuronal circuitry (McBain and Fisahn 2001; Huang et al. 2007) .
Brain derived neurotrophic factor (BDNF) and its highaffinity receptor TrkB have been widely implicated in the differentiation and maturation of the inhibitory local circuits (Vicario-Abejon et al. 1998; Huang et al. 1999; Rico et al. 2002; Carmona et al. 2006) . For example, transgenic overexpression of BDNF promotes the maturation of inhibitory synapses in the visual system and prematurely enhances the onset of the visual critical period plasticity (Hanover et al. 1999; Huang et al. 1999 ). In addition, BDNF has been associated with the activitydependent regulation of c-aminobutyric acidergic (GABAergic) synapse formation and maintenance (Rutherford et al. 1997; Hong et al. 2008; Sakata et al. 2009 ).
The main neurotransmitter used by inhibitory interneurons in the cerebral cortex is GABA, which is synthesized by 2 distinct glutamic acid decarboxylase enzymes: GAD67 and GAD65, encoded by the Gad1 and Gad2 genes, respectively (Erlander et al. 1991) . Different subpopulations of interneurons differ in their content of GAD67 or GAD65 proteins, which suggests that expression of both enzymes is differentially regulated (Esclapez et al. 1994; Esclapez and Houser 1995; Sloviter et al. 1996; Fukuda et al. 1997; Betley et al. 2009 ). The subcellular localization of GAD67 and GAD65 is also different. GAD67 is located in several subcellular compartments, whereas GAD65 is predominantly found in synaptic terminals, coupling GABA synthesis with transport into synaptic vesicles (Erlander et al. 1991; Kaufman et al. 1991; Esclapez et al. 1994; Jin et al. 2003) . Besides their divergent cellular and subcellular localizations, different functions have been ascribed to each of these GAD isoforms. GAD67 produces the vast majority of GABA in the brain in basal conditions (Asada et al. 1996) , whereas GAD65 is essential during periods of peaked synaptic activity. Thus, GAD65 mutants show defective GABA release during sustained synaptic activation, increased susceptibility to spontaneous seizures, and altered ocular dominance plasticity during the critical period combined with impaired induction of early long-term depression (LTD) (Kash et al. 1997; Hensch et al. 1998; Tian et al. 1999; Choi et al. 2002) . These defects occur in the absence of dramatic changes in GABA levels, reinforcing the view that GAD65 and GAD67 differentially control GABA synthesis and availability on GABAergic synapses.
Previous studies have shown that GAD65 mRNA or protein levels are likely modulated by BDNF and TrkB (Rico et al. 2002; Aguado et al. 2003; Carmona et al. 2003 Carmona et al. , 2006 . However, the mechanisms through which BDNF/TrkB signaling controls the expression of inhibitory synaptic proteins remain unknown. Here, we provide novel insights into the molecular pathways through which BDNF/TrkB signaling regulates the level of GAD65 protein expression in the mammalian cerebral cortex. Using the Cre/LoxP recombination system, we generated mice that lack TrkB in cortical interneurons. We found that TrkB signaling cell autonomously controls GAD65 by regulating GAD65 mRNA expression and, consequently, GAD65 protein levels in inhibitory presynaptic terminals. The dissection of the intracellular molecular pathway underlying this process revealed that BDNF/TrkB signaling increases the transcription of GAD65 through the Ras/ERKs pathway, which promotes the binding of the activated form of CREB, phospho-CREBSer133, to the transcriptional starting site (TSS) proximal region of the GAD65 promoter. Our findings shed light into the molecular mechanisms through which BDNF and its TrkB receptor control the expression of GAD65, a process required for the maturation and function of inhibitory circuits in the cerebral cortex.
Materials and Methods

Mice
Mice lacking TrkB in neocortical interneurons and their controls littermates were generated by breeding mice carrying a loxP-flanked TrkB allele, fBZ (Xu et al. 2000) , with a transgenic strain in which Dlx5/ 6 regulatory elements drive the expression of Cre and Gfp (Dlx5/6-Cre-IRES-Gfp). This Cre strain targets the recombination of floxed genes in subpallial-derived telencephalic cells, including early postmitotic GABAergic interneurons that will populate the cerebral cortex as well as in the ventral diencephalon (Stenman et al. 2003) . GABA terminals analyzed in our study most likely belong to cortical GABAergic interneurons, although we cannot exclude a small contribution of GABAergic inputs from Dlx5/6 territories outside the neocortex.
Both strains were kept on a C57BL/6 background. In brief, interneuron-specific TrkB mutant (Dlx5/6-Cre-IRES-Gfp;TrkB fBZ/fBZ ) were obtained in the F2 by crossing the F1 double heterozygous Dlx5/ 6-Cre-IRES-Gfp;TrkB fBZ/+ with TrkB fBZ/+ heterozygous mice. In the fBZ conditional allele, Cre-mediated recombination and subsequent TrkB gen deletion are reported by the expression of a tau-lacZ cassette under the control of TrkB promoter (Xu et al. 2000; Rico et al. 2002) . Imprinting control region 1 wild-type mice were used for gain of function experiments. Animals were kept at the Instituto de Neurociencias de Alicante under Spanish and European Union regulations. It is worth noting that Cre expression driven by Dlx5/6 sometimes jumped into the parental germ line in the Dlx5/6-Cre-IRESGfp;TrkB fBZ/+ genotype (F1) causing the recombination of LoxP sites during spermatogenesis or oogenesis. The parental Dlx5/6-Cre-IRESGfp;TrkB fBZ/+ (F1) can, therefore, transmit randomly the recombined TrkB null allele to its offspring (F2). This phenomenon has been previously reported for other neuronal Cre lines (Rempe et al. 2006 .
Cell Cultures
Neocortical cultures were prepared from E17.5--18.5 mouse embryos as previously described (Xu et al. 2004) . In brief, cortices were dissected, treated with 0.25% trypsin (Invitrogen) during 15 min at 37°C, and dissociated into single cells by gentle trituration. Neurons were resuspended in ''plating medium'' (Dulbecco's Modified Eagle Medium [DMEM] containing 10% fetal bovine serum [FBS] , penicillin/streptomycin [pen/strep] and Glutamax) and then plated on glass coverslips (300 000 cells/well in 12 well plates) or on plastic plates (8 000 000/ 10 cm) coated with 0.5 mg/mL poli-L-lysine (Sigma) and 5 lg/mL laminin (Sigma). After 2 h, the plating medium was replaced by ''maintenance medium'' (B27 supplement, pen/strep, 0.6% glucose and Glutamax-all products from Invitrogen). Maintenance medium was refreshed every 4--5 days for the neurons cultured in 12 wells (1/2 of the medium) and every day after 4 DIV in neurons cultured in 10-cm plates (1/3 of the medium). Neurons were stimulated with BDNF (Peprotech) diluted in semiconditioned-maintaining medium (semiconditioned-maintaining medium [SCM] refreshed with 1/2 new maintenance medium) during short-term (5--20 min) or long-term (12--16 h) periods. Experiments were carried out with 100 ng/mL of BDNF, as previously described (Brene´et al. 2000; Bamji et al. 2006; Matsumoto et al. 2006; Zhang et al. 2006) . HEK293 and NIH3T3 cell lines were grown in DMEM-containing Glutamax and pen/strep medium supplemented with 10% FBS for HEK293 and calf serum for NIH3T3.
Histology, Immunohistochemistry, and Immunocytochemistry P15 mice were anesthetized and perfused with phosphate-buffered saline (PBS) followed by 4% paraformaldehyde. Brains were removed, postfixed 2 h, cryoprotected with sucrose-PBS solutions (15--30%) and transversally sectioned in a sliding microtome at 40 lm. X-Gal staining was performed and counterstained with Fast-Red as previously described (Funfschilling and Reichardt 2002) . For immunofluorescence, 40-lm free-floating sections were incubated with blocking solution during 1 h at room temperature (RT) followed by primary antisera incubation overnight at 4°C. Briefly, for triple immunolabeling: blocking solution (2% bovine serum albumin [BSA]-Sigma, 2% horse serum, HS-Invitrogen, and 0.1% Triton X-100 in PBS), primary antisera solution (mouse anti-b-galactosidase, b-gal, 1:1000-Promega, chicken anti-GFP, 1:1000-Aves Labs, and rabbit anti-GABA, 1:4000-Sigma antibodies, diluted in 1% BSA with 0.1% Triton X-100). For GAD65 immunostaining: blocking solution (10% normal goat serum, NGS-ATOM and 0.3% Triton X-100 in PBS), primary antisera solution (mouse anti-GAD6 antibody, 1:100-DSHB diluted in 1% NGS, 0.3% Triton X-100-PBS). GABA immunostaining was performed as previously described (Flames et al. 2004) . In all experiments, sections from TrkB conditional mutants and control littermates were processed together. For immunocytochemistry, neuronal cultures were fixed with 4% paraformaldehyde/4% sucrose for 20 min at RT, permeabilized with 0.25% Triton X-100 for 10 min, blocked in a solution containing 10% HS, and incubated in 1% HS overnight at 4°C with the following primary antibodies: mouse anti-b-gal (1:1000), GAD65 (1:500, Chemicon), TrkB (1:100, BD Biosciences), rabbit anti-GABA (1:4000), Serine 133 phosphorylation of the transcription factor CREB (pCREBSer133, 1:1000, Upstate), goat anti-Luciferase (1:100, Promega), and chicken anti-GFP (1:1000, Aves Labs). Secondary fluorescent antibodies used were Alexa488, Alexa555, and Alexa633 (Invitrogen). DAPI staining was applied for nuclear localization.
Immunoblotting
Postnatal brains were extracted, and cortices were dissected and homogenated in lysis buffer containing 50 mM Tris pH 7.4, 150 mM NaCl, 5mM EDTA pH 7.4, 10% glycerol, 1% Triton X-100, 0.5% sodium deoxycholate, and protease inhibitor cocktail (Complete Mini, Roche).
Lysates were clarified by centrifugation at 15 000 3 g for 10 min.
Proteins were separated by SDS-PAGE and further transferred onto nitrocellulose membranes (Whatman GmbH). Membranes were blocked with 5% BSA in TBS (20 mM Tris--HCl, pH 7.5, 150 mM NaCl) and 0.05% Tween20 for 1 h and probed with the following primary antibodies diluted in 1% BSA in TBS: mouse antibodies against GAD65 (1:500, Chemicon), GAD67 (1:2000, Chemicon), SNAP-25 (1:15000, Millipore), bIII-tubulin (1:4000, Sigma), GAPDH (1:10000, Sigma), phosphotyrosine (1:1000, Sigma) and rabbit antibodies against vesicular GABA transporter (VGAT) (1:2000, SySy), synaptophysin (1:2000, Abcam), pan-Trk (1:3000, kindly provided by Dr Martı´n-Zanca), Pp42/44, P-AKT, p42/44, and AKT (1:1000, Cell Signaling). Then, membranes were incubated with horseradish peroxidaseconjugated secondary antibodies (Pierce) and ECL Western blotting detection reagent (Immobilon, Millipore). Signals were detected with a luminescent image analyzer (LAS-1000PLUS; Fuji-firm) and quantified with Quantity One 1D Analysis Software (Bio-Rad Laboratories).
Luciferase Assays A fragment of 10.5 kb in the 5# promoter region of the rat GAD65 gene, kindly provided by B. K. Michelsen (Skak and Michelsen 1999) , was used to generate different reporter gene constructs. Conserved regions in the rat GAD65 promoter were studied using UCSC Genome Browser (http://genome.ucsc.edu/). We found a cluster of TSSs at -351/-342 bp upstream of the mouse GAD65 promoter adenin thymine guanine (ATG) (Makinae et al. 2000) . We chose the nucleotide T (-336 to ATG) as +1 reference, according to the NM_008078.2 PubMed entry. The plasmid 5.5-kb 5# GAD65-luciferase (-luc) was generated by subcloning a NcoI-NcoI 5.5 kb fragment upstream of ATG (-5227/+330 bp respect to the murine TSS) into pGL3-luc Basic vector (Promega). The plasmids 1.1 kb 5# GAD65-luc, 5.5-kb 5# GAD65-i-luc, and DCRE-GAD65-luc were generated by subcloning into the pGL3-Basic vector polymerase chain reaction (PCR) fragments generated with the following pair of primers: for 1.1 kb fragment (-777/+330 bp to murine TSS), Fwd 5-CTAACGCGTCCTCCCCCATCAACCATAAA, Rev 5#-CTAACGCGTGGGACCAGCCCTCATCTTGT; for 461 bp intron-1 fragment (+397/-858 bp to murine TSS), Fwd 5#-CATGTCGACCGGGAA-CAGGTAGGAAA, Rev 5#-CATGTCGACGCCCTTTGCACTTCTTC; and for DCRE (+62/+330 bp to murine TSS), Fwd 5#-TACCATGGTCCCC-CATTTAACCACC, Rev 5#-CAGCGGTTCCATCTTCCAGC. The search of full cAMP-response element (CRE, TGACGTCA) or half CRE (TGACG/CGTCA) sites on GAD65 promoter was performed using a rat/mouse/human GAD65 promoter alignment. Genomic DNA sequences (Rattus norvegicus-ENSRNOG00000018200, Mus musculus-ENSMUSG00000026787, and Homo sapiens-ENSG00000136750) were aligned with ClustalW2 (Larkin et al. 2007) . Other plasmids used in this work were pRC/RSV, pRC/RSV-CREB, and pRC/RSV-CREB M1 (a generous gift of A. Barco), pTK-Renilla, pGL3-Control vector (SV40-luc), and pCMVb-Gal (Promega).
Neocortical cultured neurons and cell lines were transfected at 8 DIV and just after seeding, respectively, using Lipofectamine2000 (Invitrogen) according to the manufacturer's instructions. For neocortical cultures, neurons plated in 12 wells were cotransfected with GAD65-promoter-luc constructs (1 lg) together with pTK-Renilla (100 ng) to normalize samples for transfection efficiency and sample handling. For CREB-M1 experiments, 5.5-kb 5# GAD65-luc (1 lg) was cotransfected with pRC-RSV-CREB M1 (100 ng) together with pTK-Renilla (100 ng). After 36 h, neurons were stimulated with BDNF diluted in SCM during 12 h, since the highest level of the 5# GAD65-luc promoter activation was observed after 12 h of BDNF treatment (data not shown). We used a dose of 100 ng/mL of BDNF, although our experiments indicate that 10 ng/mL of BDNF is enough to induce GAD65 activation in luciferase assays (data not shown). Luciferase assays were carried out at 10 DIV using the Dual Assay Luciferase kit (Promega). For immunocytochemistry, neurons were cotransfected with 5.5-kb 5# GAD65-luc (1 lg) and pCMV-b-Gal (500 ng) as transfection reporter. For cell lines luciferase assays, cotransfections were carried out as followed: NIH3T3 cells, GAD65-promoter-luc constructs (1 lg), and pTK-Renilla control plasmid (100 ng); HEK293 cells, GAD65-luc constructs (200 ng), pCMV-b-Gal control plasmid (8 ng), and pRC-RSV-CREB (25, 100, 200, 400 ng). Cells were lysated 24 h later and analyzed with Dual Assay Luciferase kit or b-Glo assay kit (Promega) for normalization proposes. Each experiment was performed in duplicate for each condition and replicated in 3--4 independent cultures.
Drug Treatments
All inhibitors were added to 9 DIV cultures in SCM during 30--60 min before BDNF stimulation, and they were maintained in the medium during the induction. Actinomycin D (100 nM, Sigma), K252a (100 nM, Calbiochem), U0126 (10 lM, Promega), LY294002 (25 lM, Calbiochem), and U73122 (10 lM, Calbiochem). AP5 (100 lM, Sigma) and CNQX (40 lM, Sigma) inhibitors were used only for pCREBSer133 immunofluorescence quantification experiments. They were added in SCM 2 h before starting the pathway inhibitor treatment, as previously described (Finkbeiner et al. 1997) . All the drugs were dissolved at the final concentration from stock solutions in DMSO or water according to the manufacturer's instructions. Control experiments were treated with drug vehicle. We did not observed an increase in cell death in the drug-treated neuronal cultures when compared with vehicle-treated cultures since the number of pyknotic nuclei was similar for both treatments by DAPI staining (data not shown).
Semiquantitative and Quantitative RT-PCR
For gene expression analysis, total RNA from both, 10 DIV neocortical cultures stimulated 16 h with BDNF (100 ng/mL) in SCM and from one hemineocortex of P9--12 from controls or TrkB interneuron-mutant mice, was isolated using the RNeasy mini kit (Qiagen). For each sample, 1 lg of RNA was reverse transcribed to cDNA by OligodT-priming using SuperScriptII reverse transcriptase (Invitrogen), extracted RNA was digested with DNaseI (Qiagen) prior to reverse transcription and with RNAseH (Fermentas) after cDNA generation. For semiquantitative PCR, cDNA template (2 lL), appropriated primers (0.2 lM) and recombinant Taq DNA polymerase (Biotools) were used. Reverse transcriptionquantitative polymerase chain reaction (qRT-PCR) was performed with cDNA template (1 lL of 1/20 dilution from the original sample) and SYBR Green PCR Master Mix (Applied Biosystems) in an ABI Prism 7500 sequence detector (ABI). To avoid genomic amplification, the forward and the reverse primers were designed in different exons separated by a large intron ( Supplementary Fig. 1A ). Standard curves were performed in duplicate on each plate, and samples were measured in duplicate or triplicate in 3 different dilutions. Data were normalized for each sample by the expression level of GAPDH cDNA using the comparative DDCt method (Livak and Schmittgen 2001) .
Chromatin Immunoprecipitation
Neurons cultured in 10-cm plates for 10 DIV were stimulated 60 min with BDNF in SCM medium, and chromatin immunoprecipitation (ChIP) assays were performed using the Upstate Biotechnology ChIP kit and protocols. Briefly, neurons were cross-linked with 1% formaldehyde (10 min, 37°C), rinsed twice with cold PBS, and harvested in 500 lL of SDS lysis buffer containing protease inhibitors. Samples were sheared by sonication (200 W, 40 cycles 30/30## ON/ OFF in a BioruptorTM) to 100--500 bp fragments ( Supplementary Fig.  1B ), cell debris removed by centrifugation. Sonicated chromatin was diluted 10 times, precleared for 1 h, and 1% of the supernatant was saved for immunoprecipitation (IP) input control. Protein-DNA complexes were immunoprecipitated with 7 lg of rabbit pCREBSer133 or rabbit b-gal control antibody (Eppendorf-5 Prime) overnight at 4°C. Immune complexes were collected with agarose beads for 1 h, washed and eluted twice with fresh elution buffer (1% SDS, 0.1 M NaHCO3). Cross-link was reverted in 0.2 M NaCl at 65°C during 4 h, followed by RNAse and Proteinase K digestions. The relative amounts of immunoprecipitated DNA fragments were measured by qRT-PCR using SYBR green (ABI) detection. Duplicated results were averaged, normalized by total input DNA, and expressed as fold changes over unstimulated b-gal IP value in each amplified region. CRE-flanking and negative control pairs of primers ( Supplementary Fig. 1A) were assessed with serial dilutions of genomic DNA and dissociation curves.
Imaging and Quantification
Images were acquired using a fluorescence microscope Leica DM5000B coupled to a digital camera Leica DC500 or a confocal microscope TCS-SP2 AOBS (Leica Microsystems, GmbH). To quantify GFP/GABA/b-gal colocalization, confocal images from 10 fields per animal were acquired along superficial layers (II and III) of prefrontal cortex (Bregma: 2.96--2.80). Quantification of GABA cell total density and density by layers (I--III, superficial layers, IV--VI, deep layers) in the neocortex was measured blindly in slices from 3 animals of each genotype using Neurolucida software (MBF Bioscience). To measure GAD65-ir in the boutons, comparable areas in prefrontal cortex (layers II and III) were chosen, and 10 fields from lateral to medial were acquired with a 633 objective (zoom = 4) at 1024 3 1024 pixel resolution with all pixel intensities within the dynamic range of the detector. Within each field, we selected an area of 100 lm 2 placed in the upper right corner of each field. Using ImageJ software (NIH), background was subtracted, and gray intensity level of each bouton found within this area of 100 lm 2 per field was measured. Thus, 150--200 boutons per animal were sampled. Bouton population was distributed, in ranges of intensity, respect to the maximum bouton intensity value in the wild-type animal of each litter. Counts were performed blindly in slices taken from 3 animals of each genotype. Confocal images from cultured neurons immunolabeled with pCREBSer133 antibody were acquired in the middle of the nucleus of GAD65 positive interneurons with a 633 objective (zoom = 4) at 1024 3 1024 pixel resolution. Fluorescence intensity was measured with ImageJ as described above. The intensity of luciferase signal was measured in the soma of transfected GABAergic neurons by using ImageJ software as described before.
Results
Conditional Ablation of TrkB in Neocortical Interneurons
To explore first whether TrkB is specifically required for the differentiation of synaptic inhibitory circuits in the neocortex, we generated interneuron-specific conditional TrkB mutants by crossing Dlx5/6-Cre-ires-Gfp (Dlx5/6-Cre) mice with mice carrying a TrkB conditional allele (fBZ; Supplementary Fig. 2 ). Dlx5/6-Cre is expressed in subpallial-derived telencephalic cells, including the cortical interneurons and in ventral diencephalon cells (Stenman et al. 2003) . Consistent with previous analysis in cortex using BDNF and TrkB complete Cerebral Cortex April 2011, V 21 N 4 779 knockout mice (Jones et al. 1994; Carmona et al. 2006) , specific targeting of TrkB in cortical interneurons did not alter the area of the neocortex, neither the number nor position of GABAergic cells in neocortex ( Supplementary Fig. 3 ). As expected, however, the defects found in TrkB interneuron-specific mutants are largely restricted to the GABAergic system. Thus, TrkB signaling is cell autonomously required in interneurons to maintain the normal levels of several GABAergic markers in the neocortex (GAD67, GAD65, and the VGAT). Among these markers, the presynaptic inhibitory marker GAD65 seems the most sensitive to TrkB function, since it remained downregulated throughout postnatal development (Fig. 1A--C and Supplementary Fig. 4) . Consistently, we found a prominent decrease in the amount of synaptic GAD65 in cortical interneurons in TrkB interneuron-specific mutants (Fig. 1D--G) .
The quantity of GAD65 protein can be modulated at different levels (Wei and Wu 2008) . In particular, we found that GAD65 mRNA levels in TrkB interneuron-specific mutants were roughly half of those found in control mice, which suggested that TrkB function is necessary for normal GAD65 transcription in cortical interneurons (Fig. 1H) . In sum, our results suggested that the loss of TrkB signaling in cortical interneurons leads to a reduction in the levels of GAD65 protein at synaptic terminals, which may be caused by decreased transcription of the GAD65 gene.
BDNF/TrkB Signaling Regulates GAD65 Transcription
To understand the molecular mechanisms through which BDNF/TrkB signaling may modulate GAD65 transcription, we carried out neocortical cultures and performed gainof-function experiments by stimulating with BDNF at different times. We first examined Trk tyrosine phosphorylation after short-term BDNF stimulation. As expected, BDNF treatment resulted in an increased of TrkB tyrosine phosphorylation in cultured neurons, which was blocked with the cell-permeable Trk inhibitor K252a (Supplementary Fig. 5A ). We also found that long-term BDNF induction leads to a 2-fold increase in the levels of GAD65 protein. This effect was mediated by the activation of Trk receptors, since it was blocked with the inhibitor K252a ( Fig. 2A,B) . The increase of GAD65 protein triggered by BDNF was also abolished in the presence of the transcriptional inhibitor Actinomycin D (Fig. 2C,D) , which reinforced the view that BDNF/TrkB signaling controls the transcription of GAD65. To confirm this hypothesis, we carried out RT-PCR experiments with total RNA extracted from neocortical cultures stimulated with BDNF. We found a substantial increase in GAD65 transcripts after BDNF stimulation (Fig. 2E ). These results were further supported by qRT-PCR experiments, which revealed a 2.5-fold increase in the levels of GAD65 mRNA in BDNF-stimulated cultures compared with Figure 1 . TrkB signaling in neocortical interneurons is necessary for normal GABAergic protein and mRNA expression levels, particularly of the synaptically enriched protein GAD65. (A, B) GABAergic protein expression in homogenates from neocortex of 2-week-old (A) and 3-week-old (B) TrkB interneuron mutant mice. (C) Densitometric analysis of GAD65, GAD67, and VGAT in controls (TrkB floxed) and TrkB interneuron mutants (Dlx5/6-Cre;TrkB floxed, n 5 3 for each genotype, each brain extract was loaded by triplicate in different membranes and results were averaged). bIII-Tubulin or GAPDH were used for protein normalization. The protein levels of the 3 GABAergic markers are reduced (~30--40%) in the TrkB interneuron-specific mutants compared with control in 2-week-old mice (A, C). GAD65 protein level remains decreased (35 ± 1% of reduction) in 3-week-old mutants but no GAD67 or VGAT. **P \ 0.01, *P \ 0.05, ns, not significant, P 5 0.675 and P 5 0.167 for GAD67 and VGAT, respectively by t-test. (D--F) Pseudocolored images based on fluorescence intensity from confocal sections taken at superficial layers (II and III) of prefrontal cortex at P15 showing GAD65-ir inhibitory presynaptic boutons (see color scale, high-intensity levels in white). Control wild-type (D), control TrkB floxed (E), and TrkB interneuron mutant, Dlx5/6-Cre;TrkB floxed (F). (G) Distribution of GAD65-bouton population in GAD65-ir intensity intervals in controls (wild type and TrkB floxed) and TrkB interneuron mutants (n 5 3 for each genotype, 10 fields each, 1751 boutons). *P \ 0.05, one-way ANOVA followed by Bonferroni's post hoc test (analysis in each intensity interval group). (H) qRT-PCR from neocortical extracts of P10--P12 mice. Data were normalized with GAPDH using DDCt method (n 5 4 for each genotype). *P \ 0.05, Kruskal--Wallis test, followed by Mann--Whitney U test. ns, not significant. No significant differences were found between control genotypes in all experiments. Histograms show means ± standard error of the mean. Scale bar: 2 lm (D--F).
controls (Fig. 2F) . Altogether, our results strongly suggested that BDNF/TrkB signaling controls the expression of GAD65 by regulating its transcription.
GAD65 Promoter Activity Is Regulated by BDNF
Having obtained evidence that BDNF/TrkB signaling triggers the transcription of GAD65, we sought next to identify the DNA regulatory sequences that mediate this process. We used the UCSC Genome Browser (Karolchik et al. 2008) to compare the sequences of putative GAD65 promoter regions from different mammals. We found several highly conserved sequences in 3 different locations: 1) within the~1-kb region immediately 5# of the ATG, 2) in a~2.5-kb region upstream of the ATG, and 3) within the first intron ( Supplementary Fig. 6 ). To test their activity, we cloned several promoter constructs containing these sequences into the ''firefly'' luciferase (luc) reporter system (Fig. 3A) . We assessed the basal activity of these constructs by performing dual luciferase assays in mouse primary neocortical cultures or mouse NIH3T3 (3T3) fibroblasts (Fig. 3B) . We used 3T3 fibroblasts as a negative control because these cells do not express GAD65 mRNA (Pinal et al. 1997; Skak and Michelsen 1999) . In cultured cortical neurons, all 5# GAD65-luc constructs led to a 6 to 12-fold increase in luciferase activity over the basal activity but little or no activity in 3T3 cells (Fig. 3A,B) . These results revealed that 5# GAD65-luc constructs are neuron specific and can be basally activated by factors present in neocortical cultures.
To investigate whether BDNF regulated GAD65 promoter activity, we repeated the previous experiments in the presence of BDNF and/or the Trk inhibitor K252a (Fig. 3C) . Our results revealed that the 3 transfected 5#-flanking GAD65-luc constructs were similarly activated by BDNF, which suggested that the putative regulatory regions mediating this effect are contained within the -777/+330 bp respect to the murine TSS. Interestingly, we found a higher activation ratio with the long (5.5 kb) promoter construct than with the short one (1.1 kb) (1.56 folds ± 0.04 respect to 1.34 folds ± 0.06; t-test; P < 0.05). This result suggested that although the majority of BDNF-regulated elements in the GAD65 promoter lied within the -777/+330 TSS region, other putative regulatory elements were located upstream of these region (Fig. 3C) . For all the constructs, BDNF-mediated GAD65 transcriptional activation was completely blocked by K252a, this result is consistent with the idea that transcriptional regulation of these 5# GAD65-luc constructs requires tyrosine kinase receptor function (Fig. 3C) .
To extend the previous observations at the cellular level, we monitored the activity of the long promoter construct (5.5-kb 5# GAD65-luc) by immunocytochemistry. We observed that both pyramidal and GABAergic cells expressed this construct (data not shown) which suggested that additional elements outside the 5.5-kb 5# GAD65 fragment control the cell-type specificity of GAD65 expression or that epigenetic events limit GAD65 expression in the endogenous locus. Then, considering that GABA cells represented only 20 ± 2% of total transfected neurons in our cortical cultures (n = 275 transfected neurons from 3 different cultures), we analyzed the effect of BDNF specifically in GABAergic neurons. We found that BDNF induced a significant activation of the GAD65 promoter in transfected GABA-ir cells (Fig. 3D) . This result reinforced the view that 5# regulatory elements of GAD65 gene are positively regulated by BDNF in GABAergic interneurons.
BDNF Activates GAD65 Transcription in a MAPKDependent Manner BDNF binding to TrkB leads to autophosphorylation of several tyrosine residues on the cytoplasmic domain of this receptor. Phosphorylation of these residues creates docking sites for several adapter proteins and enzymes that couple TrkB receptor to several intracellular signaling cascades, including the Ras/ ERKs, PI3-K, and PLCc pathways (Huang and Reichardt 2003) . To investigate which one of these signaling cascades is involved in the activation of GAD65 transcription in response to BDNF, we studied the effect of specific inhibitors of these pathways (U0126, LY294002, and U73122 for ERKs, PI3-K, and PLCc, respectively) in luciferase assays. We first validated the usefulness of these inhibitors in neocortical cultures (Supplementary Fig. 5B--D ). Subsequently, we tested whether addition of U0126, LY294002, or U73122 prior to BDNF treatment could block the activation of GAD65 transcription. We found that the Ras/ERK pathway inhibitor U0126 completely abolished the activation of 5.5-kb 5# GAD65-luc construct trigged by BDNF (Fig. 4A) . In contrast, we observed no effect on 5# GAD65-luc construct activation when inhibiting the PI3-K pathway (LY294002) and only a partial blockage in the presence of the PLCc inhibitor U73122 (Fig. 4A) . Our results therefore suggested that BDNF/TrkB signaling regulates GAD65 transcription primarily through the Ras/ERK signaling cascade.
BDNF Increases CREB Phosphorylation in GABAergic Neurons
Activation of the Ras-ERKs pathway mediated by BDNF/TrkB signaling has been shown to trigger Serine 133 phosphorylation of the transcription factor CREB (pCREBSer133) in neurons (Finkbeiner et al. 1997) . CREB phosphorylation initiates the recruitment of CREB-interacting proteins to the CREs present in CREB target genes (Shaywitz and Greenberg 1999) , promoting transcription. Since CREB is a major mediator of neuronal neurotrophic response in other cellular contexts (Bonni et al. 1995; Finkbeiner et al. 1997) , we next tested whether BDNF/TrkB signaling could lead to CREB activation in neocortical GABAergic neurons. To this end, we quantified pCREBSer133 immunofluorescence in the nucleus of cultured interneurons with or without BDNF. Compared with controls, we found that BDNF increased pCREBSer133-ir in the nuclei of GAD65+ cells after 15 min of BDNF stimulation (Fig. 4B--D) . Inhibition of the Ras/ERK signaling cascade with the U0126 inhibitor strongly abolished this effect (Fig. 4C,D) , which demonstrated that BDNF/TrkB signaling promotes CREB phosphorylation in GABAergic neurons via the Ras/ERK pathway. CREB Is a Transcriptional Activator of the 5.5-kb 5# GAD65 Promoter To investigate whether CREB was responsible for mediating the transcriptional activation of the GAD65 gene induced by BDNF/ TrkB signaling, we searched for conserved CREs within the 5# flanking region of GAD65. The alignment of the orthologous regions of the rat, mouse, and human genomes flanking the 5# region of the GAD65 gene is illustrated in Figure 5A . Although CREB was originally identified by its ability to bind a palindromic element (TGACGTCA), many CREB binding elements consist only of half palindromes (TGACG/CGTCA) or contain multiple substitutions (Montminy et al. 1986; Mayr and Montminy 2001) . Consistently, we found 3 putative half palindromic CRE sites (CRE3: -1862/-1857; CRE2: -591/-586; CRE1: -33/-28 all relative to the murine TSS) within the analyzed sequences (Fig. 5A) . While CRE1 and CRE3 showed partial or no conservation in humans, CRE2 was fully conserved in all 3 species. These findings suggested that CREB could directly modulate GAD65 expression. To test this hypothesis, we next performed gain of function experiments in HEK293 cells, in which the neural 5.5-kb 5# GAD65 promoter-luc construct was not basally active. In brief, we cotransfected the 5.5-kb 5# GAD65-luciferase reporter plasmid along with increasing doses of a CREB full-length expressing vector. We found that CREB activated the 5.5-kb 5# GAD65-luc construct in a dose-dependent manner (Fig. 5B) . In contrast, the activity of the luciferase reporter promoted by CREB was abolished when a modified version of the 5# GAD65-luc construct lacking all 3 CRE sites (DCRE-luc, +62/+330 to TSS) was used (Fig. 5B) . These results indicated that CREB is able to modulate the activity of the 5# regulatory region of the GAD65 gene by interacting within a region upstream of the 268-bp promoter.
To investigate whether BDNF-dependent activation of the GAD65 promoter also relied onto this CRE-rich region of the promoter in neurons (upstream of the 268-bp promoter region), the activity of DCRE-luc was tested in neocortical cultures stimulated with BDNF. We found that BDNF failed to increase the activity of this reporter (Fig. 5C ), which indicated that the BDNF-regulated elements in the GAD65 promoter are located beyond the proximal 268 bp region of the GAD65 gene.
To directly test the relevance of CREB in mediating the effect of BDNF/TrkB signaling in the transcription of GAD65, we performed additional luciferase assays using a form of CREB that carries a mutation preventing its phosphorylation at Ser133 (CREB M1) (Gonzalez and Montminy 1989) . We found that expression of CREB M1 effectively prevented the stimulation of 5' GAD65-luc activity by BDNF (Fig. 6A) . .5-kb 5# GAD65-luc construct stimulated with BDNF in the presence of U0126 (10 lM), LY294002 (25 lM), and U73122 (10 lM) inhibitors. 5.5-kb 5# GAD65-luc data was normalized with respective pGL3b data (n 5 3 independent experiments). ***P \ 0.001, *P \ 0.05, ns, not significant, P 5 0.556 by one-way ANOVA followed by Tukey's post hoc test. (B) Confocal planes showing triple labeling against GAD65 (red), DAPI (blue), and pCREBSer133 (green) in neocortical cultures stimulated with BDNF in SCM. (C, D) Analysis of immunoreactivity of pCREBSer133 in cultured interneurons after BDNF stimulation with vehicle or U0126 inhibitor (n 5 200 interneurons from 3 independent experiments). (C) Mean ± standard error of the mean of pCREBSer133-ir in the analyzed interneurons (***P \ 0.001, *P \ 0.05, Mann--Whitney and Kurskal--Wallis). (D) The cumulative distribution of nuclear pCREBSer133-ir in BDNF-treated cultures significantly shifted to the right (P \ 0.001, Kolmogorov--Smirnov test) respect to control. In the presence of ERKs inhibitor (U0126), the shift produced by BDNF in the cumulative distribution of pCREBSer133 (P \ 0.05, Kolmogorov--Smirnov test) was strongly reduced respect to vehicle-BDNF condition (P \ 0.001, Kolmogorov--Smirnov test). White arrowheads (GAD65þ) and open arrowheads (GAD65À). Scale bar: 5 lm (B).
Although, expression of TrkB receptor can be increased by cAMP/CREB pathway in neurons (Deogracias et al. 2004 ), this is not the case in our experimental model since the neurons transfected with CREB M1 showed normal levels of TrkB immunoreactivity in the soma (Supplementary Fig. 7 ). These results demonstrated that BDNF-induced GAD65 transcriptional activation involves phosphorylation of CREB at Ser133.
BDNF Promotes CREB Binding to GAD65 Regulatory Regions
To test whether CREB directly binds the regulatory regions of the GAD65 gene in vivo, we performed ChIP assays with GABAergic cells. We focused our attention in the 2 best conserved CRE elements (CRE2 and CRE1) flanking the mouse GAD65 gene and used an intergenic region located at -4400 as a negative control for the experiments (Fig. 6B,C and Supplementary Fig. 1A ). We found no significant increase in P-CREB binding to the distal CRE-containing region (CRE2) in BDNF-treated cultures compared with controls (Fig. 6C) . In contrast, we detected a 10-fold increase in phospho-CREB binding to the proximal CRE-containing region CRE1 after BDNF treatment (Fig. 6C) . Along with our previous results, these experiments strongly suggested that the GAD65 gene is a direct target of the phosphorylated form of CREB and that this process is induced by BDNF via TrkB and the Ras-ERKs pathway.
Discussion
Normal functional output of principal cells requires the temporal and spatial dynamics of inhibition in the network, which is under the control of the main inhibitory neurotransmitter in vertebrate brain, GABA. Previous studies have shown that GABA synthesis by GAD65 plays a crucial role in synaptic plasticity in the visual cortex, a process known to be modulated by BDNF (Hensch et al. 1998; Hanover et al. 1999; Huang et al. 1999; Choi et al. 2002) . Consistent with this notion, expression of GAD isoforms and protein was found to be perturbed in BDNF-overexpressing and TrkB mutant mice (Rico et al. 2002; Carmona et al. 2003 Carmona et al. , 2006 Hong et al. 2008) . Despite this knowledge, our understanding of the mechanisms through which BDNF might control GABA synthesis in inhibitory terminals remained unknown. In this study, we decipher a molecular pathway through which BDNF/TrkB signaling cell autonomously controls the transcriptional regulation of the gene encoding for the synaptically enriched GAD isoform, GAD65. We provide genetic evidence showing that specific ablation of TrkB in cortical interneurons causes a prominent decrease in protein and transcript levels of GAD65. This is Figure 5 . CREB is a potential candidate to modulate GAD65 promoter activity. (A) Sequence alignment of the orthologous regions of mouse, rat, and human genomes at 5# flanking GAD65 promoter. Sites are numbered in relation to the transcription start site previously described (TSS, bold, and arrow above) in the murine GAD65 transcript (NM 008078.2), placed À336 bp upstream the ATG. Putative CRE sites are shadowed in gray. GAD65 promoter lacks of a canonical TATA-box but contains a CCAAT-box (underlined, þ31/þ38). (B) GAD65 promoter-luc construct is dose dependently activated by CREB. HEK293 cells were cotransfected with 5.5-kb 5# GAD65-luc or DCRE-GAD65-luc deletion mutant (a 268-bp promoter fragment proximal to ATG) with pCMV-b-Gal and the indicated dose of pRCRSV-CREB and luciferase activity was measured (n 5 3 independent experiments). Statistic analysis was done between the reporter constructs at the corresponding CREB dose. ***P \ 0.001, **P \ 0.01, one-way ANOVA followed by Bonferroni's post hoc test. (C) Neocortical cultures transfected with DCRE-GAD65-luc deletion mutant stimulated with BDNF. Graph showing luciferase activity of the DCRE-GAD65-luc deletion mutant (n 5 4 independent experiments). **P \ 0.01, t-test. Histogram shows average ± standard error of the mean.
consistent with the finding of reduced GAD65-ir in presynaptic terminals located in the neocortex of interneuron-specific TrkB conditional mice. BDNF/TrkB signaling controls this process by directly regulating the transcription of the GAD65 gene through a pathway that involves Ras/ERK and CREB, which directly activate GAD65 transcription in cortical GABAergic interneurons. In sum, our results reveal a novel molecular mechanism through which BDNF controls the maturation of inhibitory circuits by orchestrating the expression of one of the enzymes responsible for GABA synthesis, GAD65. Aguado et al. 2003; Carmona et al. 2003; Patz et al. 2003; Ohba et al. 2005; Carmona et al. 2006; Matsumoto et al. 2006; Hong et al. 2008 ). Our results demonstrate that these changes in GAD65 are due to the function of TrkB specifically in interneurons and that transcriptional regulation is involved.
Gene transcription is the first regulatory step controlling protein expression, and it is mediated by the concerted action of many transcription factors. Among them, CREB, a major mediator of neuronal neurotrophic responses (Bonni et al. 1995; Finkbeiner et al. 1997) , has been involved in synaptic development and long-term plasticity (Dash et al. 1990; Bourtchuladze et al. 1994; Pham et al. 2001) . CREB function in transcription seems to be tightly regulated by phosphorylation at Ser133, which is thought to be essential for the recruitment of CREB-interacting proteins and the formation of a transcriptional complex (for review, see Shaywitz and Greenberg 1999) . Phosphorylation of CREB at serine 133 is triggered in response to a variety of stimuli, such as increased intracellular Ca2+, increased cAMP levels, or activation of tyrosine kinase receptors by growth factors. In the case of BDNF, previous studies have found that this neurotrophin activates CREB through both the Ras/ERK and PLCc-Ca 2+ -CaMKs pathways (Finkbeiner et al. 1997; Pizzorusso et al. 2000) . In addition, recent studies have shown that BDNF induces the expression of several genes in the striatum in a MAPK-dependent manner (Gokce et al. 2009 ). Also, GAD2 transcript levels seem to be increased in the striatum of CREBoverexpressing transgenic mice (McClung and Nestler 2003) . Our study demonstrated for the first time that the regulation of GAD65 is at the promoter level since: 1) GAD65-luc constructs are activated upon BDNF stimulation; 2) this activation seems to be primarily mediated by the Ras/ERKs pathway, although a minor involvement of PLCc signaling cannot be discarded; 3) this process is also induced by CREB in a dose-dependent manner; 4) GAD65 promoter activation in response to BDNF depends on Ser133 CREB phosphorylation; and 5) our ChIP analysis in GABAergic cells demonstrated that activated CREB (pCREBSer133) binds in vivo to the TSS-proximal region of the endogenous GAD65 promoter after BDNF treatment. These findings are particularly relevant in the context of synapse maturation and long-term plasticity, where CREB has been frequently implicated (Bourtchuladze et al. 1994; Pham et al. 2001; Barco et al. 2002) . In particular, recent studies have suggested that CREB regulates the development of inhibitory synapses through activity-dependent regulation of the BDNF gene (Hong et al. 2008; Sakata et al. 2009 ). Our study demonstrates that GAD65 is a direct target for CREB. Thus, the impaired inhibitory circuit observed in the activity-dependent BDNF transcription mutant (Hong et al. 2008; Sakata et al. 2009 ) might be explained, at least in part, by defective Gad2 activation in response to BDNF-TrkB signaling.
Recent studies have suggested that BDNF might not be required for the expression of the GAD65 gene in spinal cord interneurons (Betley et al. 2009 ). This is in contrast with our experiments, which indicate that BDNF/TrkB signaling in the cortex indeed controls the transcriptional regulation of GAD65. It is conceivable that BDNF/TrkB signaling is differentially involved in the maturation and plasticity of the GABAergic system in the spinal cord and in the cortex. For example, GABAergic neuronal fate in the spinal cord depends on the Ptf1 transcription factor, which is not expressed in the cerebral Figure 6 . CREB phosphorylation is implicated in the transcriptional activation of GAD65 induced by BDNF. (A) CREB M1 (S133A) dominant negative or empty plasmid were cotransfected with 5.5-kb 5# GAD65-luc in neocortical cultures (n 5 3 independent experiments). *P \ 0.05, **P \ 0.01, t-test (A, B). Statistic analysis was done respect to the corresponding control condition. (B) Schematic diagram of murine GAD65 promoter illustrating the regions analyzed in the ChIP experiments. (C) Chromatin IP analysis with anti-pCREBSer133 antibody in extracts of 10 DIV neocortical cultures stimulated with BDNF in SCM. Anti-b-gal was used as control antibody for the IP. An intergenic region between GAD65 (À4400 bp from murine TSS) and the previous gene Myo3a without any near CRE site was used as binding negative control. Data are presented as fold changes of % input over the unstimulated b-gal IP value (n 5 3 independent experiments). **P \ 0.01 one-way ANOVA followed by Bonferroni's post hoc test (C). Histograms show average ± standard error of the mean of 3 experiments.
Cerebral Cortex April 2011, V 21 N 4 785 cortex (Glasgow et al. 2005) . Furthermore, it is likely that regulation of cortical GAD65 by BDNF/TrkB signaling may not only depend on transcription, as illustrated by our study, but may also rely on transcription-independent mechanisms such as synaptic localization, as shown in the spinal cord.
GABA Regulation in Inhibitory Neuronal Networks
GABA is the major inhibitory neurotransmitter in the vertebrate brain. In contrast to other neurotransmitters, GABA is synthesized by 2 different enzymes, GAD67 and GAD65, which are encoded by the Gad1 and Gad2 genes, respectively. There are significant differences in the regulation and function of both enzymes (Erlander et al. 1991; Kaufman et al. 1991; Martin et al. 1991; Szabo et al. 1996; Fukuda et al. 1997; Pinal et al. 1997 ) (present study). Why does the production of a single neurotransmitter have such a complex and tight regulation? A plausible explanation is that both enzymes are involved in different aspects of GABA-mediated neurotransmission depending on particular requirements of the neuron during development and adulthood. Interestingly, the levels of GAD67 and GAD65 proteins vary in different classes of hippocampal interneurons (Fukuda et al. 1997 ). In particular, GABA produced at perisomatic synapses made by parvalbumin-expressing interneurons mostly comes from GAD67 synthesis, whereas GABA present in synapses targeting the dendrites of pyramidal cells in CA1 (primarily made by interneurons that do not contain parvalbumin) is mainly synthesized by GAD65 (Fukuda et al. 1998) . Thus, the different functions of these distinct classes of interneurons (Klausberger and Somogyi 2008) might demand different requirements in GABA production and regulation. Indeed, it has been suggested that GAD65 is specialized to respond to short-term changes in demand for GABA (Martin and Rimvall 1993) , for example, during sustained stimulation (Tian et al. 1999; Choi et al. 2002) . Future studies will be required to explore whether the segregation of GAD enzymes reported in CA1 is also found in other cortical regions. In addition, GAD65 function has been associated with plasticity-related tasks, such as ocular dominance plasticity during the critical period and induction of early LTD in the visual cortex, since all of these functions are impaired in GAD65 knockouts (Hensch et al. 1998; Tian et al. 1999; Choi et al. 2002) . Interestingly, BDNF has also been associated with the long-term modulation and maturation of inhibitory circuits (Rutherford et al. 1997) , processes in which CREB is also required (Bourtchuladze et al. 1994; Pham et al. 2001; Barco et al. 2002; Hong et al. 2008 ). Considering our results, it is conceivable that activity-dependent release of BDNF by pyramidal neurons may influence inhibitory circuits by triggering GAD65 transcription in a CREB-dependent manner, which would increase the synaptic levels of GABA in a particular subset of interneurons, thereby modulating the activity of the network.
Alterations in the development of inhibitory neurons by genetic or epigenetic factors may influence the precise spatial organization or plasticity of neural circuits, leading to wiring abnormalities and aberrant process information. For example, polymorphisms in the BDNF gene and alterations in the expression of GAD67 or GAD65 in the prefrontal cortex have been associated with schizophrenia and bipolar disorders (Benes et al. 2000 (Benes et al. , 2007 Heckers et al. 2002; Neves-Pereira et al. 2002; Sklar et al. 2002; Rybakowski et al. 2003; Hashimoto et al. 2005 ; Hashimoto and Lewis 2006). Interestingly, GAD65 knockout mice have deficits in prepulse inhibition, a sensorimotor gating deficit that is reversed by antipsychotic drugs (Heldt et al. 2004) . Consistently, treatment with antipsychotic drugs increases GAD65 levels in bipolar patients (Todtenkopf and Benes 1998; Benes et al. 2000; Laeng et al. 2004) . Unraveling the mechanisms that controls synapse formation and plasticity in the GABAergic system may help us to understand the precise alterations that occur in some of these neurodevelopmental disorders and, eventually, contribute to the design of new therapeutic strategies.
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